Volume 272, Number 40,
Issue of October 3, 1997
pp. 24876-24884
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Distinct Substrate Specificities and Functional Roles for the 78- and 76-kDa Forms of µ-Calpain in Human Platelets
(Received for publication, May 12, 1997, and in revised form, July 7, 1997)
Simone M.
Schoenwaelder
,
Suhasini
Kulkarni
,
Hatem H.
Salem
,
Shinobu
Imajoh-Ohmi
¶
,
Wakako
Yamao-Harigaya
,
Takaomi C.
Saido
and
Shaun P.
Jackson
**
From the
Department of Medicine, Monash Medical
School, the Australian Centre for Blood Diseases, and the ** Department
of Pathology, Box Hill Hospital, Victoria 3128, Australia, the
¶ Institute of Medical Science, University of Tokyo, Tokyo 108, and the
Tokyo Metropolitan Institute of Medical Science, Tokyo
113, Japan
The intracellular thiol protease µ-calpain
exists as a heterodimeric proenzyme, consisting of a large 80-kDa
catalytic subunit and a smaller 30-kDa regulatory subunit. Activation
of µ-calpain requires calcium influx across the plasma membrane and
the subsequent autoproteolytic conversion of the 80-kDa large subunit
to a 78-kDa "intermediate" and a 76-kDa fully autolyzed form.
Currently, there is limited information on the substrate specificities
and functional roles of these distinct active forms of µ-calpain
within the cell. Using antibodies that can distinguish among the 80-, 78-, and 76-kDa forms of µ-calpain, we have demonstrated a close
correlation between the autolytic generation of the 78-kDa enzyme and
the proteolysis of the non-receptor tyrosine phosphatase, PTP-1B, in
ionophore A23187-stimulated platelets. Time course studies revealed
that pp60c-src proteolysis lagged well behind
that of PTP-1B and correlated closely with the generation of the fully
proteolyzed form of µ-calpain (76 kDa). In vitro
proteolysis experiments with purified µ-calpain and
immunoprecipitated PTP-1B or pp60c-src confirmed
selective proteolysis of pp60c-src by the 76-kDa
enzyme, whereas PTP-1B cleavage was mediated by both the 76- and 78-kDa
forms of µ-calpain. Studies using selective pharmacological
inhibitors against the different autolytic forms of µ-calpain have
demonstrated that the initial conversion of the µ-calpain large
subunit to the 78-kDa form is responsible for the reduction in
platelet-mediated clot retraction, whereas complete proteolytic
activation of µ-calpain (76 kDa) is responsible for the shedding of
procoagulant-rich membrane vesicles from the cell surface. These
studies demonstrate the existence of multiple active forms of
µ-calpain within the cell, that have unique substrate specificities
and distinct functional roles.